Rigel D F, Lathrop D A
Department of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Ohio.
Circ Res. 1990 Dec;67(6):1323-33. doi: 10.1161/01.res.67.6.1323.
Our study was designed to determine the cardiac electrophysiological influence of vasoactive intestinal polypeptide (VIP) in conscious dogs. Dogs (n = 8) were chronically instrumented with arterial and venous catheters, cervical vagal cooling coils, and right atrial and right ventricular bipolar epicardial pacing and recording electrodes. After autonomic blockade (10 mg/kg i.v. hexamethonium, 0.11 mg/kg i.v. atropine, and vagal cold blockade), VIP (50 and 100 pmol/kg/min i.v.) or isoproterenol (ISO) (250 and 500 pmol/kg/min i.v.) increased heart rate (maximum increases: VIP, 81.1 +/- 4.2 beats/min; ISO, 61.3 +/- 8.5 beats/min), decreased the atrial-ventricular interval (during constant atrial pacing) (VIP, -41.9 +/- 6.3 msec; ISO, -34.6 +/- 7.4 msec), shortened the atrial effective refractory period (VIP, -24.4 +/- 2.1 msec; ISO, -30.6 +/- 4.4 msec) and ventricular effective refractory period (VIP, -4.2 +/- 0.7 msec; ISO, -10.0 +/- 2.4 msec), and decreased mean arterial pressure (VIP, -51.9 +/- 4.0 mm Hg; ISO, -26.1 +/- 2.4 mm Hg). beta-Adrenergic blockade with propranolol (1 mg/kg i.v.) eliminated the positive chronotropic and atrioventricular nodal dromotropic responses to bolus doses of ISO (30, 100, 300, and 1,000 pmol/kg i.v.) but did not affect the responses to VIP (10, 30, 100, and 300 pmol/kg i.v.). Comparable blood pressure decreases produced by sodium nitroprusside caused only minimal changes in heart rate, atrial-ventricular conduction times, and atrial and ventricular refractory periods. In three additional anesthetized dogs, after vagotomy and beta-adrenergic blockade (1 mg/kg i.v. propranolol), VIP (100 pmol/kg/min i.v.) shortened the atrial-His interval but did not alter intra-atrial, intraventricular, or His-Purkinje conduction. Our findings combined with the demonstration by others of VIP-immunoreactive nerves innervating canine sinus nodal cells, atrioventricular nodal cells, and atrial and ventricular myocardial cells suggest that endogenous VIP may directly alter the electrical properties of the heart.
我们的研究旨在确定血管活性肠肽(VIP)对清醒犬心脏电生理的影响。犬(n = 8)长期植入动脉和静脉导管、颈迷走神经冷却线圈以及右心房和右心室双极心外膜起搏和记录电极。在自主神经阻滞(静脉注射六甲铵10 mg/kg、阿托品0.11 mg/kg以及迷走神经冷阻滞)后,VIP(静脉注射50和100 pmol/kg/min)或异丙肾上腺素(ISO)(静脉注射250和500 pmol/kg/min)可使心率增加(最大增加幅度:VIP为81.1±4.2次/分钟;ISO为61.3±8.5次/分钟),使房室间期缩短(在恒定心房起搏期间)(VIP为-41.9±6.3毫秒;ISO为-34.6±7.4毫秒),缩短心房有效不应期(VIP为-24.4±2.1毫秒;ISO为-30.6±4.4毫秒)和心室有效不应期(VIP为-4.2±0.7毫秒;ISO为-10.0±2.4毫秒),并降低平均动脉压(VIP为-51.9±4.0毫米汞柱;ISO为-26.1±2.4毫米汞柱)。静脉注射普萘洛尔(1 mg/kg)进行β肾上腺素能阻滞可消除对大剂量ISO(静脉注射30、100、300和1000 pmol/kg)的正性变时性和房室结变传导性反应,但不影响对VIP(静脉注射10, 30, 100和300 pmol/kg)的反应。硝普钠引起的类似血压下降仅使心率、房室传导时间以及心房和心室不应期产生极小变化。在另外三只麻醉犬中,在迷走神经切断和β肾上腺素能阻滞(静脉注射普萘洛尔1 mg/kg)后,VIP(静脉注射100 pmol/kg/min)缩短了心房-希氏束间期,但未改变心房内、心室内或希氏束-浦肯野纤维传导。我们的研究结果与其他人所证实的支配犬窦房结细胞、房室结细胞以及心房和心室心肌细胞的VIP免疫反应性神经相结合,提示内源性VIP可能直接改变心脏的电特性。